MDX — Medx Health Income Statement
0.000.00%
Last trade - 00:00- CA$16.40m
- CA$24.83m
- CA$0.49m
Annual income statement for Medx Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.53 | 0.563 | 0.511 | 0.456 | 0.49 |
| Cost of Revenue | |||||
| Gross Profit | 0.268 | 0.273 | 0.24 | 0.186 | 0.194 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.73 | 5.89 | 5.64 | 5.04 | 4.14 |
| Operating Profit | -3.2 | -5.32 | -5.13 | -4.58 | -3.65 |
| Net Income Before Taxes | -3.2 | -5.32 | -5.13 | -4.58 | -3.65 |
| Net Income After Taxes | -3.2 | -5.32 | -5.13 | -4.58 | -3.65 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.2 | -5.32 | -5.13 | -4.58 | -3.65 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.2 | -5.32 | -5.13 | -4.58 | -3.65 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.019 | -0.03 | -0.028 | -0.026 | -0.014 |